SNSE/MRK (SNSE/MRK)

Santiago Stock Exchange: SNSE/MRK · USD

$141

-3.02 (-2.1%)· Recorded snapshot

Market cap	344.6T
Revenue (ttm)	61.3T
Net income (ttm)	2.9T
EPS (ttm)	$1,254
P/E (trailing)	110.5x
P/E (forward)	16.8x
Dividend	$3,150 (2.27%)
Beta	0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 61.3T
Net income (ttm): 2.9T
EPS (ttm): $1,254
P/E (trailing): 110.5x
P/E (forward): 16.8x
Market cap: 344.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E110.5

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All SNSE/MRK indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

USD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-29
Employees	75,000
Employees change	0
Employees growth	0%
Enterprise value	$390.6T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US58933Y1055
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Market cap	$344.6T
Next earnings date	2026-10-29
Price	$140.61
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	snse/MRK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	56.04x
Average P/E ratio (3Y)	100.29x
Average P/E ratio (5Y)	71.09x
Earnings yield	0.91%
EV/Earnings	133.28x
EV/EBIT	16.89x
EV/EBITDA	13.54x
EV/FCF	26.33x
EV/Sales	5.96x
FCF / EV yield	3.8%
FCF yield	4.31%
Forward P/E	16.83x
Graham number	20.6392
Graham upside	-85.32%
Lynch fair value	$5.98
Lynch upside	-95.75%
P/(FCF - SBC) ratio	24.59x
P/(OCF - SBC) ratio	19.55x
P/B ratio	8.88x
P/E ratio	110.47x
P/FCF ratio	23.22x
P/OCF ratio	18.68x
P/S ratio	5.6x
Price/EBITDA ratio	12.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.28%
EBITDA margin	43.37%
Effective tax rate	46.72%
FCF margin	22.57%
Gross margin	75.9%
Operating margin	35.28%
Pretax margin	8.94%
Profit margin	4.77%
Profit per employee	$39.5M
Profitable years	35
Revenue per employee	$828.8M
ROA	11.87%
ROA (5Y)	11.18%
ROCE	23.01%
ROE	6.96%
ROE (5Y)	30.37%
ROIC	14.05%
ROIC (5Y)	22.36%
SBC / revenue	1.34%
Tax / revenue	4.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-80.37%
EPS growth 10Y	-3.53%
EPS growth 3Y	1.25%
EPS growth 5Y	-10.38%
EPS growth years	2
FCF growth	9.11%
FCF growth (Q)	77.03%
FCF growth (QoQ)	52.96%
FCF growth 3Y	14.05%
FCF growth 5Y	18.23%
Gross profit growth	2.6%
Gross profit growth (Q)	0.52%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	9.69%
Net income growth	-80.66%
Net income growth 3Y	0.66%
Net income growth 5Y	-10.64%
Net income growth years	2
OCF growth	7.73%
OCF growth (Q)	63.07%
OCF growth (QoQ)	37.06%
OCF growth 10Y	5.83%
OCF growth 3Y	9.82%
OCF growth 5Y	10.91%
Operating income growth	-1.53%
Operating income growth 3Y	5.7%
Operating income growth 5Y	13.81%
Revenue growth	4.64%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	1.97%
Revenue growth 10Y	5.37%
Revenue growth 3Y	4.51%
Revenue growth 5Y	8.68%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-3.6T
Depreciation and amortization	$5.3T
EBIT	$21.6T
EBITDA	$26.6T
EPS	$1,253.75
Financing cash flow	$5.7T
Free cash flow	$14.8T
Free cash flow minus SBC	$14T
Gross profit	$46.5T
Income taxes	$2.6T
Investing cash flow	$-25.1T
Net borrowing	$18.4T
Net cash flow	$-1.1T
Net income	$2.9T
Operating cash flow minus SBC	$17.6T
Operating income	$21.6T
Revenue	$61.3T
Stock-based compensation	$821.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.6
Book value per share	$15,649.43
Debt / EBITDA	1.84
Debt / equity	1.28
Debt / FCF	3.36
Goodwill	$21.3T
Interest coverage	13.47
Long-term assets	$83.5T
Long-term liabilities	$53.6T
Net cash (debt)	$-43.1T
Net cash / market cap	-12.54%
Net debt / EBITDA	1.62
Net debt / equity	1.11
Net debt / FCF	2.91
Piotroski F-Score	4
Property, plant and equipment	$25.4T
Shareholders' equity	$38.7T
Tangible book value	$-4.3T
Tangible book value per share	$-1,726.80
Total assets	$119.6T
Total cash	$6.6T
Total debt	$49.7T
Total liabilities	$80.9T
WACC	5.82%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	$36.1T
Current liabilities	$27.3T
Current ratio	1.32
Inventory turnover	2.51
Net working capital	$4.3T
Quick ratio	0.74
Working capital	$8.2T
Working capital turnover	6,140.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.92%
Dividend growth	4.94%
Dividend growth (10Y)	6.33%
Dividend growth (3Y)	5.2%
Dividend growth (5Y)	5.51%
Dividend growth years	13
Dividend payment date	2026-10-07
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	$3,150.48
Dividend yield	2.28%
Ex-dividend date	2026-09-15
Last dividend	$0.85
Payout ratio	261.52%
Shareholder yield	4.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	123.23%
10Y return CAGR	11.7%
10Y total return	202.39%
150-day SMA	$129.17
1D price change	-2.1%
1M price change	-5.95%
1M total return	-5.95%
1W price change	-0.96%
1W total return	-0.96%
1Y price change	77.67%
1Y return CAGR	82.89%
1Y total return	82.82%
20-day SMA	$143.39
200-day SMA	$125.76
3M price change	13.03%
3M total return	13.68%
3Y price change	35.54%
3Y return CAGR	13.95%
3Y total return	47.99%
50-day SMA	$145.13
50-day SMA vs 200-day SMA	50over200
52-week high	$150.66
52-week high date	2026-09-07
52-week low	$79.14
52-week low date	2025-12-02
5Y price change	73.81%
5Y return CAGR	15.05%
5Y total return	101.56%
6M price change	19.46%
6M total return	21.02%
All-time high	$150.66
All-time high date	2026-08-25
All-time low	$45.43
All-time low date	2013-05-17
Average true range (ATR)	$0.81
Average volume	0
Beta (5Y)	0.39
Change from 52-week high	-6.67%
Change from 52-week low	77.67%
Change from all-time high	-6.67%
Change from all-time low	209.51%
Monthly RSI	66.86
Previous close	$143.63
Price vs 150-day SMA	8.85%
Price vs 20-day SMA	-1.94%
Price vs 200-day SMA	11.8%
Price vs 50-day SMA	-3.11%
Relative volume	20
RSI	36.21
Sharpe ratio	1.71
Sharpe ratio (3Y)	0.46
Sharpe ratio (5Y)	0.55
Sortino ratio	7.15
Sortino ratio (3Y)	0.8
Sortino ratio (5Y)	1.04
Weekly RSI	60.46
YTD price change	37.31%
YTD total return	40.12%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	-0.08%
Shares change (YoY)	-1.92%
Shares held by insiders	0.05%
Shares held by institutions	81.18%
Short ratio	2.6 days

Deeper analysis on SNSE/MRK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this SNSE/MRK report

Is a complete SNSE/MRK research report available?

No complete published report is available for snse/MRK (SNSE/MRK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

344.6T

Revenue (ttm)

61.3T

Net income (ttm)

2.9T

EPS (ttm)

$1,254

P/E (trailing)

110.5x

P/E (forward)

16.8x

Dividend

$3,150 (2.27%)

Beta

0.39

Metric

Value

Amount currency

CLP

Country

United States

Country code

Earnings date

2026-10-29

Employees

75,000

Employees change

Employees growth

Enterprise value

$390.6T

Exchange

Santiago Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1891

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

US58933Y1055

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Market cap

$344.6T

Next earnings date

2026-10-29

Price

$140.61

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

snse/MRK

Website

https://www.merck.com

Metric

Value

Average P/E ratio (10Y)

56.04x

Average P/E ratio (3Y)

100.29x

Average P/E ratio (5Y)

71.09x

Earnings yield

0.91%

EV/Earnings

133.28x

EV/EBIT

16.89x

EV/EBITDA

13.54x

EV/FCF

26.33x

EV/Sales

5.96x

FCF / EV yield

3.8%

FCF yield

4.31%

Forward P/E

16.83x

Graham number

20.6392

Graham upside

-85.32%

Lynch fair value

$5.98

Lynch upside

-95.75%

P/(FCF - SBC) ratio

24.59x

P/(OCF - SBC) ratio

19.55x

P/B ratio

8.88x

P/E ratio

110.47x

P/FCF ratio

23.22x

P/OCF ratio

18.68x

P/S ratio

5.6x

Price/EBITDA ratio

12.92x

Metric

Value

EBIT margin

35.28%

EBITDA margin

43.37%

Effective tax rate

46.72%

FCF margin

22.57%

Gross margin

75.9%

Operating margin

35.28%

Pretax margin

8.94%

Profit margin

4.77%

Profit per employee

$39.5M

Profitable years

Revenue per employee

$828.8M

ROA

11.87%

ROA (5Y)

11.18%

ROCE

23.01%

ROE

6.96%

ROE (5Y)

30.37%

ROIC

14.05%

ROIC (5Y)

22.36%

SBC / revenue

1.34%

Tax / revenue

4.17%

Metric

Value

EPS growth

-80.37%

EPS growth 10Y

-3.53%

EPS growth 3Y

1.25%

EPS growth 5Y

-10.38%

EPS growth years

FCF growth

9.11%

FCF growth (Q)

77.03%

FCF growth (QoQ)

52.96%

FCF growth 3Y

14.05%

FCF growth 5Y

18.23%

Gross profit growth

2.6%

Gross profit growth (Q)

0.52%

Gross profit growth 3Y

5.77%

Gross profit growth 5Y

9.69%

Net income growth

-80.66%

Net income growth 3Y

0.66%

Net income growth 5Y

-10.64%

Net income growth years

OCF growth

7.73%

OCF growth (Q)

63.07%

OCF growth (QoQ)

37.06%

OCF growth 10Y

5.83%

OCF growth 3Y

9.82%

OCF growth 5Y

10.91%

Operating income growth

-1.53%

Operating income growth 3Y

5.7%

Operating income growth 5Y

13.81%

Revenue growth

4.64%

Revenue growth (Q)

5.07%

Revenue growth (QoQ)

1.97%

Revenue growth 10Y

5.37%

Revenue growth 3Y

4.51%

Revenue growth 5Y

8.68%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

$-3.6T

Depreciation and amortization

$5.3T

EBIT

$21.6T

EBITDA

$26.6T

EPS

$1,253.75

Financing cash flow

$5.7T

Free cash flow

$14.8T

Free cash flow minus SBC

$14T

Gross profit

$46.5T

Income taxes

$2.6T

Investing cash flow

$-25.1T

Net borrowing

$18.4T

Net cash flow

$-1.1T

Net income

$2.9T

Operating cash flow minus SBC

$17.6T

Operating income

$21.6T

Revenue

$61.3T

Stock-based compensation

$821.8B

Metric

Value

Altman Z-Score

3.6

Book value per share

$15,649.43

Debt / EBITDA

1.84

Debt / equity

1.28

Debt / FCF

3.36

Goodwill

$21.3T

Interest coverage

13.47

Long-term assets

$83.5T

Long-term liabilities

$53.6T

Net cash (debt)

$-43.1T

Net cash / market cap

-12.54%

Net debt / EBITDA

1.62

Net debt / equity

1.11

Net debt / FCF

2.91

Piotroski F-Score

Property, plant and equipment

$25.4T

Shareholders' equity

$38.7T

Tangible book value

$-4.3T

Tangible book value per share

$-1,726.80

Total assets

$119.6T

Total cash

$6.6T

Total debt

$49.7T

Total liabilities

$80.9T

WACC

5.82%

Metric

Value

Asset turnover

0.54

Current assets

$36.1T

Current liabilities

$27.3T

Current ratio

1.32

Inventory turnover

2.51

Net working capital

$4.3T

Quick ratio

0.74

Working capital

$8.2T

Working capital turnover

6,140.37

Metric

Value

Buyback yield / dilution

1.92%

Dividend growth

4.94%

Dividend growth (10Y)

6.33%

Dividend growth (3Y)

5.2%

Dividend growth (5Y)

5.51%

Dividend growth years

Dividend payment date

2026-10-07

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$3,150.48

Dividend yield

2.28%

Ex-dividend date

2026-09-15

Last dividend

$0.85

Payout ratio

261.52%

Shareholder yield

4.19%

Metric

Value

10Y price change

123.23%

10Y return CAGR

11.7%

10Y total return

202.39%

150-day SMA

$129.17

1D price change

-2.1%

1M price change

-5.95%

1M total return

-5.95%

1W price change

-0.96%

1W total return

-0.96%

1Y price change

77.67%

1Y return CAGR

82.89%

1Y total return

82.82%

20-day SMA

$143.39

200-day SMA

$125.76

3M price change

13.03%

3M total return

13.68%

3Y price change

35.54%

3Y return CAGR

13.95%

3Y total return

47.99%

50-day SMA

$145.13

50-day SMA vs 200-day SMA

50over200

52-week high

$150.66

52-week high date

2026-09-07

52-week low

$79.14

52-week low date

2025-12-02

5Y price change

73.81%

5Y return CAGR

15.05%

5Y total return

101.56%

6M price change

19.46%

6M total return

21.02%

All-time high

$150.66

All-time high date

2026-08-25

All-time low

$45.43

All-time low date

2013-05-17

Average true range (ATR)

$0.81

Average volume

Beta (5Y)

0.39

Change from 52-week high

-6.67%

Change from 52-week low

77.67%

Change from all-time high

-6.67%

Change from all-time low

209.51%

Monthly RSI

66.86

Previous close

$143.63

Price vs 150-day SMA

8.85%

Price vs 20-day SMA

-1.94%

Price vs 200-day SMA

11.8%

Price vs 50-day SMA

-3.11%

Relative volume

RSI

36.21

Sharpe ratio

1.71

Sharpe ratio (3Y)

0.46

Sharpe ratio (5Y)

0.55

Sortino ratio

7.15

Sortino ratio (3Y)

0.8

Sortino ratio (5Y)

1.04

Weekly RSI

60.46

YTD price change

37.31%

YTD total return

40.12%

Metric

Value

Float

2.5B

Shares change (QoQ)

-0.08%

Shares change (YoY)

-1.92%

Shares held by insiders

0.05%

Shares held by institutions

81.18%

Short ratio

2.6 days

SNSE/MRK (SNSE/MRK)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/MRK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/MRK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/MRK

Frequently asked questions

SNSE/MRK (SNSE/MRK)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/MRK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/MRK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/MRK

Frequently asked questions